Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06567015 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 171 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Pierre Fabre Medicament |
| Last Updated on CT.gov | September 17, 2025 (Sep 17, 2025) |
As of March 2, 2026: Clinical trial NCT06567015 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Pierre Fabre Medicament. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06567015 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06567015 was last updated Sep 17, 2025 (September 17, 2025). HelloStudys verifies this status automatically.